Saving Lives and Improving Profitability with Big Data Analytics | Cloudera + GlaxoSmithKline
A signal of change
GSK (GlaxoSmithKline) Aktienanalyse 2023: Wie sicher ist die Dividende? Jetzt günstig bewertet?
Pfizer, GlaxoSmithKline join forces on OTC drugs
GlaxoSmithKline involved in a corruption scandal in China
GlaxoSmithKline Found Guilty of Bribery in China
Unilever signals pursuit of GSK consumer arm
GSK: Harnessing the Explosion of Medical Data for Transformative Treatments on Cambridge-1
💊 GlaxoSmithKline Pharmaceuticals Total income up by 6.1%YoY, PAT at ₹252.5 crores,16% YoY increase
Glaxo Gets Ready to Split in Two
GlaxoSmithKline Fined $3 Billion
The David Rubenstein Show: GSK CEO Emma Walmsley
GlaxoSmithKline: GSK investigator warns over China - BBC News
GSK – Our story
Pharmaceutical giant GlaxoSmithKline closer to splitting in two
Bad Medicine: The Glaxo Case
[2022] Pass the GSK Interview | GSK Video Interview
Drugmaker GlaxoSmithKline 'guilty of fraud'
Is GlaxoSmithKline a Top Pharma Stock? | $GSK Stock Analysis
GlaxoSmithKline CEO: I Don't Define Work By My Gender